Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 328 entries
View as:

SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed

Phase: N/A Priority: Normal
NCT ID: NCT00002551 Org: User:
Start: 03/31/94 End: 10/31/08 Due: 10/31/09

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00003723 Org: User:
Start: 02/28/99 End: 12/31/07 Due: 12/31/08

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Phase: N/A Priority: Normal
NCT ID: NCT04510597 Org: User:
Start: 03/08/21 End: 07/31/33 Due: 07/31/34

S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00898183 Org: User:
Start: 11/30/96 End: 02/28/07 Due: 02/28/08

Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04268550 Org: User:
Start: 04/08/20 End: 12/01/25 Due: 12/01/26

S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00068367 Org: User:
Start: 12/31/03 End: 08/31/09 Due: 08/31/10

S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006487 Org: User:
Start: 10/31/00 End: 07/31/04 Due: 07/31/05

S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00015938 Org: User:
Start: 05/31/01 End: 11/30/12 Due: 11/30/13

S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00661193 Org: User:
Start: 12/31/08 End: 12/31/16 Due: 12/31/17

S9005 Mifepristone in Meningioma

Phase: N/A Priority: Normal
NCT ID: NCT03015701 Org: User:
Start: 08/31/92 End: 11/30/12 Due: 11/30/13

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00005866 Org: User:
Start: 02/29/00 End: 03/31/06 Due: 03/31/07

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT01453452 Org: User:
Start: 03/31/12 End: 01/31/17 Due: 01/31/18

S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00075764 Org: User:
Start: 04/30/04 End: 10/01/18 Due: 10/01/19

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05890352 Org: User:
Start: 09/26/23 End: 01/31/29 Due: 01/31/30

S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT00003416 Org: User:
Start: 09/30/98 End: 01/31/04 Due: 01/31/05

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00042783 Org: User:
Start: 09/30/02 End: 03/31/06 Due: 03/31/07

S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone

Phase: N/A Priority: Normal
NCT ID: NCT00933127 Org: User:
Start: 12/31/08 End: 06/30/12 Due: 06/30/13

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005047 Org: User:
Start: 08/31/97 End: 12/31/14 Due: 12/31/15

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00002665 Org: User:
Start: 07/31/95 End: 12/31/03 Due: 12/31/04

S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00095641 Org: User:
Start: - End: - Due: -

S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00064038 Org: User:
Start: 11/30/04 End: 05/31/12 Due: 05/31/13

Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT03971474 Org: User:
Start: 05/28/19 End: 01/01/24 Due: 01/01/25

S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00090961 Org: User:
Start: 09/30/04 End: 10/31/08 Due: 10/31/09

S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003587 Org: User:
Start: 10/31/98 End: 01/31/07 Due: 01/31/08

S0820, Adenoma and Second Primary Prevention Trial

Phase: N/A Priority: Normal
NCT ID: NCT01349881 Org: User:
Start: 08/23/13 End: 02/01/32 Due: 02/01/33